Does CABOZANTINIB S-MALATE Cause Oedema peripheral? 226 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 226 reports of Oedema peripheral have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.6% of all adverse event reports for CABOZANTINIB S-MALATE.
226
Reports of Oedema peripheral with CABOZANTINIB S-MALATE
0.6%
of all CABOZANTINIB S-MALATE reports
37
Deaths
79
Hospitalizations
How Dangerous Is Oedema peripheral From CABOZANTINIB S-MALATE?
Of the 226 reports, 37 (16.4%) resulted in death, 79 (35.0%) required hospitalization, and 4 (1.8%) were considered life-threatening.
Is Oedema peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 226 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Oedema peripheral?
AMBRISENTAN (2,959)
TREPROSTINIL (2,816)
ADALIMUMAB (2,356)
LENALIDOMIDE (2,298)
AMLODIPINE (2,076)
PREDNISONE (2,029)
METHOTREXATE (1,939)
MACITENTAN (1,932)
RITUXIMAB (1,698)
TOCILIZUMAB (1,574)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Oedema peripheral Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE